Abstract: Fifteen flavonoids, 1-7 and 9-16, and a polyacetylene, 8, were isolated from the ethanol extract of the dried whole plant of Bidens parviflora Willd. by various chromatographic techniques. Their structures have been elucidated on the basis of spectroscopic analyses and chemical studies. Compound 8 is new and was identified as 3-(R),8(E)-decene-4,6-diyne-1,3,10-triol. All the flavonoid compounds were isolated for the first time from this plant species.
Introduction
The plant Bidens parviflora Willd. is used in Chinese folk medicine as an antipyretic, antiinflammatory and antirheumatic [1, 2] . Flavones [3] , flavonones [4] , flavonoid glycosides [3, 5] , flavonol glycosides [6, 7] , chalcones [8, 9] , aurones [7, 8] , sterols [10] , polyacetylene glucosides [4, 9] and monoterpenes [4, 10] have all been previously reported in this species. In our previous studies, sucrose esters [11] , phenolic acids [12] , polyacetylene glucosides [13] , monoterpene glycosides [14] ,
OPEN ACCESS
neolignan glucosides [15] , phenolic glucosides [16] and caffeoylquinic acid derivatives [17] were isolated from this plant. As a part of an ongoing research program, this paper describes the isolation and structural determination of a new ployacetylene, 8, and 15 known flavonoids from B. parviflora Willd. (Figure 1 ). 
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Results and Discussion
Compounds 1-7 and 9-16 were identified as acacetin (9) , taxifolin (10), 2′-hydroxy-3,4,4′,6′-tetramethoxychalcone (11), kaempferol (12), luteolin (13) , quercetin (14) , sulfuretin (15) upfield, suggesting an effect of the MTPA pheyl ring [19] . In contrast, H-8, H-9 and H-10 were downfield from the corresponding S-(-)-MTPA ester. The result was shown in Figure 3 . Thus, the absolute configuration at C-3 of 8 was determined to be R. 
Experimental
General
UV spectra were measured in MeOH using a Shimadzu UV2401PC spectrophotometer (Shimadzu Co., Japan) and optical rotations were determined on a JASCO P-1020 polarimeter in MeOH. IR spectra were recorded on a Shimadau FTIR8400 spectrophotometer (Shimadzu Co., Japan) using KBr discs as stated. ESI-MS were obtained using a Bruker Esquire 2000 mass spectrometer (Bruker Co., Germany) and HR-ESI-MS were recorded on a Micromass Q-TOF mass spectrometer. NMR spectra were recorded on a Bruker AVANCE 400 NMR spectrometer ( 1 H at 400 MHz, 13 C at 100 MHz, Bruker Co., Germany). Chemical shifts (δ) are shown in ppm relative to TMS as internal standard and coupling constants (J) are given in Hz. The solvent used was DMSO-d 6 , unless otherwise stated. Preparative HPLC was carried out on a Shimadzu Pak equipped with a UV-Vis detector (Shimadzu Co., Japan) using a Shim-pack PREP-ODS column (5 μ, 10×250 mm, Shimadzu Co., Japan). Open column chromatography was carried out on D101 macroporous adsorption resin (Tianjin Nankai Daxue Chemical Plant, P. R. China), silica gel H60 (200-300 mesh, Qingdao Haiyang Chemical Group Co., P. R. China), Sephadex LH-20 (Amersham Pharmacia Biotech Co., UK) and ODS (60-80 μm, Merck Co., Germany) as packing materials. Thin-layer chromatography was performed on silica gel H60 plates (Qingdao Haiyang Chemical Group Co., P.R. China) and RP-18 plate (Merck Co., Germany).
Plant material
The whole plant material of Bidens parviflora Willd. was collected in July 2003 in Liaoning province, P.R. China, and was identified by Prof. Weichun Wu (Department of Medical Plants, Shenyang Pharmaceutical University, Shenyang, P.R. China). A voucher specimen (99-DHS-953) was deposited in the herbarium of the Department of Natural Products Chemistry, Shenyang Pharmaceutical University, Shenyang, P. R. China.
Extraction and Isolation
The dried whole plant of B. parviflora Willd. (6.0 kg) was extracted three times with 60% EtOH (48 L) under reflux. The resulting EtOH extract (704 g) was dissolved in water (1.0 L) and applied to a D101 macroporous adsorption resin column, then eluted with water, 30% EtOH, 50% EtOH and 95% EtOH, respectively, to yield four fractions. The 30% EtOH eluate (BPB, 72 g) was subjected to silica gel column chromatography using a gradient solvent system (CHCl 3 -MeOH = 100: 0→ 98: 2→ 95: 5→ 9: 1→ 8: 2→ 7: 3→ 6: 4→ 0: 1) to give twelve fractions BPB-1 to BPB-12. The BPB-3 fraction (5.45 g) was subjected to ODS column chromatography, eluted with gradient of increasing MeOH (MeOH-H 2 O = 20: 80→ 40: 60→ 60: 40→ 90: 10), to give six fractions BPB-3a to BPB-3e; BPB-3c (940 mg) was purified by silica gel chromatography (gradient elution separation with a CHCl 3 -MeOH system: 95: 5→ 9: 1→ 85: 15→ 8: 2), followed by preparative HPLC (ODS, MeOH-H 2 O = 48:52) to yield compounds 1 (10 mg) and 2 (13 mg). BPB-3d (1.85 g) was subjected to Sephadex LH-20 column chromatography (MeOH-H 2 O = 50:50), followed by preparative HPLC (ODS, MeOH-H 2 O = 55:45) to obtained 3 (68 mg) and 4 (25 mg). The BPB-6 fraction (7.24 g) was subjected to ODS column chromatography, eluted with an increasing gradient of MeOH (MeOH-H 2 O = 10:90→ 30:70→ 50:50→ 70:30) to give six fractions BPB-6a to BPB-6e. BPB-6b (2.40 g) and BPB-6c (2.02 g) were subjected to Sephadex LH-20 column chromatography (MeOH-H 2 O = 1:1), followed by ODS column chromatography and preparative HPLC (ODS, MeOH-H 2 O = 35: 65) to yield 5 (12 mg), 6 (45 mg), 7 (13 mg), 8 (30 mg) and 9 (22 mg).
The 60% EtOH eluate (BPC, 48 g) was subjected to silica gel column chromatography using a gradient solvent system (hexane-acetone =100: 0→ 98: 2→ 95: 5→ 9: 1→ 8: 2→ 7: 3→ 6: 4→ 0: 1) to give twelve fractions BPC-1 to BPC-12. Fraction BPC-1 (3.34 g) was subjected to silica gel column chromatography, eluted with hexane and ethyl acetate in increasing order of polarity, to give eight fractions BPC-1a to BPC-1h. BPC-1g (107 mg) was purified with Sephadex LH-20 column chromatography (CHCl 3 -MeOH = 1:1) to yield 10 (23 mg). BPC-3 (5.43 g) and BPC-6 (3.06 g) were subjected to Sephadex LH-20 column chromatography (CHCl 3 -MeOH = 1:1) followed by silica gel column chromatography (gradient elution separation with CHCl 3 -acetone system) to obtain 11 (30 mg), 12 (24 mg), 13 (15 mg), 14 (20 mg), 15 (16 mg) and 16 (10 mg). 
Acacetin 7-O-(α-D-apio-furanosyl) (1→6)-β-D-glucoside
